Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis
Journal of the National Comprehensive Cancer Network · 2026-11 · 24 (11)
DOI: 10.6004/jnccn.2026.7054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-11. Verfasst von Tamryn L Fowler und 43 weiteren Autor:innen. Beteiligte Einrichtung: 1School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Clinical Trials as Topic, Patient Participation. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Only 3%–5% of patients with cancer nationwide enroll in clinical trials. Although participation among patients with solid tumors has been well studied, data in the hematopoietic stem cell transplantation (HSCT) setting remain limited. We sought to (1) describe clinical trial participation rates by HSCT type; (2) examine associations between patient, disease, and transplant characteristics and trial participation; and (3) explore the association between trial participation and overall survival (OS).
Methods
We conducted a retrospective study using Center for International Blood and Marrow Transplant Research (CIBMTR) data from US adults aged 18–75 years who underwent autologous or allogeneic HSCT between 2013 and 2019 (N=84,151; autologous: n=51,133; allogeneic: n=33,018). Logistic regression models assessed predictors of participation, while Cox models evaluated associations with OS.
Results
Trial participation was 2.0% among patients undergoing autologous HSCT and 11.1% among those undergoing allogeneic HSCT. Among autologous recipients, greater comorbidity burden was associated with lower odds of participation. Patients with multiple myeloma had higher odds than those with non-Hodgkin lymphoma (odds ratio [OR], 1.25; P =.01). Among allogeneic recipients, older adults had higher odds of participation (eg, OR, 2.19 for age ≥70 vs 18–19 years; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC.
- 2Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI.
- 3CIBMTR(Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI.
- 4Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH.
- 5Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
- 6Sarah Cannon Transplant and Cell Therapy Network, Nashville, TN.
Zitieren
APA
Fowler, T. L., Brazauskas, R., Patel, J., Rangarajan, H. G., Michelis, F. V., Battiwalla, M., Lehmann, L. E., Stefanski, H. E., Dias, A. L., Sharma, A., Beitinjaneh, A., Zeidan, A. M., Gómez-De León, A., Saad, A., Hamilton, B. K., Marks, D. I., Rizzieri, D. A., Szwajcer, D., Lad, D. P., …, & Saber, W. (2026). Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Journal of the National Comprehensive Cancer Network, 24(11). https://doi.org/10.6004/jnccn.2026.7054
Vancouver
Fowler TL, Brazauskas R, Patel J, Rangarajan HG, Michelis FV, Battiwalla M, et al. Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis. Journal of the National Comprehensive Cancer Network. 2026;24(11). doi:10.6004/jnccn.2026.7054
BibTeX
@article{Fowler2026,
author = {Fowler, Tamryn L and Brazauskas, Ruta and Patel, Jinalben and Rangarajan, Hemalatha G and Michelis, Fotios V and Battiwalla, Minoo and Lehmann, Leslie E and Stefanski, Heather E and Dias, Ajoy L and Sharma, Akshay and Beitinjaneh, Amer and Zeidan, Amer M and Gómez-De León, Andrés and Saad, Ayman and Hamilton, Betty K and Marks, David I and Rizzieri, David A and Szwajcer, David and Lad, Deepesh P and Hildebrandt, Gerhard C and Hashem, Hasan and Murthy, Hemant S and Liu, Hongtao and Preussler, Jaime M and Yared, Jean A and Aljurf, Mahmoud and de Lima, Marcos and Krem, Maxwell M and Herr, Megan M and Solh, Melhem and Abid, Muhammad Bilal and Ramanathan, Muthalagu and El Jurdi, Najla and Khera, Nandita and Majhail, Navneet S and Lulla, Premal and Seo, Sachiko and Hong, Sanghee and Chhabra, Saurabh and Ganguly, Siddhartha and Gergis, Usama and Agrawal, Vaibhav and El-Jawahri, Areej R and Saber, Wael},
title = {Factors Associated With Clinical Trial Participation in Adult Hematopoietic Stem Cell Transplantation Recipients: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {11},
doi = {10.6004/jnccn.2026.7054}
}
EUVIMED